| Title |
Pharmacological interventions for somatoform disorders in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2014
|
| DOI | 10.1002/14651858.cd010628.pub2 |
| Pubmed ID | |
| Authors |
Maria Kleinstäuber, Michael Witthöft, Andrés Steffanowski, Harm van Marwijk, Wolfgang Hiller, Michael J Lambert |
| Abstract |
Somatoform disorders are characterised by chronic, medically unexplained physical symptoms (MUPS). Although different medications are part of treatment routines for people with somatoform disorders in clinics and private practices, there exists no systematic review or meta-analysis on the efficacy and tolerability of these medications. We aimed to synthesise to improve optimal treatment decisions. |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 17% |
| Spain | 2 | 11% |
| Chile | 2 | 11% |
| New Zealand | 1 | 6% |
| Italy | 1 | 6% |
| Canada | 1 | 6% |
| Unknown | 8 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 67% |
| Practitioners (doctors, other healthcare professionals) | 4 | 22% |
| Scientists | 1 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 445 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Germany | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 442 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 66 | 15% |
| Student > Bachelor | 53 | 12% |
| Researcher | 49 | 11% |
| Student > Ph. D. Student | 40 | 9% |
| Student > Doctoral Student | 30 | 7% |
| Other | 80 | 18% |
| Unknown | 127 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 141 | 32% |
| Psychology | 54 | 12% |
| Nursing and Health Professions | 35 | 8% |
| Social Sciences | 16 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 2% |
| Other | 47 | 11% |
| Unknown | 141 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2023.
All research outputs
#1,123,404
of 25,959,914 outputs
Outputs from Cochrane database of systematic reviews
#2,284
of 13,168 outputs
Outputs of similar age
#12,599
of 279,749 outputs
Outputs of similar age from Cochrane database of systematic reviews
#50
of 259 outputs
Altmetric has tracked 25,959,914 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,168 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,749 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 259 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.